MedPath

CKD-344

Generic Name
CKD-344

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers

Phase 1
Conditions
Anticoagulant
Interventions
Drug: Lixiana(D006)
First Posted Date
2021-04-30
Last Posted Date
2021-04-30
Lead Sponsor
Chong Kun Dang Pharmaceutical
Target Recruit Count
60
Registration Number
NCT04867200
Locations
🇰🇷

H+ Yangji Hospital, Seoul, Korea, Republic of

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344

Phase 1
Conditions
Anticoagulant
Interventions
Drug: Lixiana(D006)
First Posted Date
2020-12-17
Last Posted Date
2020-12-17
Lead Sponsor
Chong Kun Dang Pharmaceutical
Target Recruit Count
50
Registration Number
NCT04673695
Locations
🇰🇷

Yook-Hwan Noh, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath